These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


244 related items for PubMed ID: 14977067

  • 1. Neuroprotective effect of combination of poly (ADP-ribose) polymerase inhibitor and antioxidant in middle cerebral artery occlusion induced focal ischemia in rats.
    Gupta S, Kaul CL, Sharma SS.
    Neurol Res; 2004 Jan; 26(1):103-7. PubMed ID: 14977067
    [Abstract] [Full Text] [Related]

  • 2. Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
    Kabra DG, Thiyagarajan M, Kaul CL, Sharma SS.
    Brain Res Bull; 2004 Feb 01; 62(5):425-33. PubMed ID: 15168908
    [Abstract] [Full Text] [Related]

  • 3. Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment.
    Ding Y, Zhou Y, Lai Q, Li J, Gordon V, Diaz FG.
    Brain Res; 2001 Oct 12; 915(2):210-7. PubMed ID: 11595210
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat.
    Singh N, Sharma G, Singh N, Hanif K.
    Int J Stroke; 2014 Jul 12; 9(5):560-8. PubMed ID: 23013350
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beneficial synergistic effects of concurrent treatment with cilostazol and probucol against focal cerebral ischemic injury in rats.
    Park SY, Lee JH, Kim CD, Rhim BY, Hong KW, Lee WS.
    Brain Res; 2007 Jul 09; 1157():112-20. PubMed ID: 17521620
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of phosphoinositide-3-kinase/Akt pathway in propofol-induced postconditioning against focal cerebral ischemia-reperfusion injury in rats.
    Wang HY, Wang GL, Yu YH, Wang Y.
    Brain Res; 2009 Nov 10; 1297():177-84. PubMed ID: 19703434
    [Abstract] [Full Text] [Related]

  • 10. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
    Abdelkarim GE, Gertz K, Harms C, Katchanov J, Dirnagl U, Szabó C, Endres M.
    Int J Mol Med; 2001 Mar 10; 7(3):255-60. PubMed ID: 11179503
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neuroprotection by the PARP inhibitor PJ34 modulates cerebral and circulating RAGE levels in rats exposed to focal brain ischemia.
    Greco R, Tassorelli C, Mangione AS, Levandis G, Certo M, Nappi G, Bagetta G, Blandini F, Amantea D.
    Eur J Pharmacol; 2014 Dec 05; 744():91-7. PubMed ID: 25446913
    [Abstract] [Full Text] [Related]

  • 17. Diphenyleneiodonium and dimethylsulfoxide for treatment of reperfusion injury in cerebral ischemia of the rat.
    Nagel S, Genius J, Heiland S, Horstmann S, Gardner H, Wagner S.
    Brain Res; 2007 Feb 09; 1132(1):210-7. PubMed ID: 17184751
    [Abstract] [Full Text] [Related]

  • 18. Neuroprotective effect of immunosuppressant FK506 in transient focal ischemia in rat: therapeutic time window for FK506 in transient focal ischemia.
    Arii T, Kamiya T, Arii K, Ueda M, Nito C, Katsura KI, Katayama Y.
    Neurol Res; 2001 Oct 09; 23(7):755-60. PubMed ID: 11680517
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.